These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7531766)

  • 1. Previous exposure to bradykinin unmasks an endothelium-dependent relaxation to the converting enzyme inhibitor trandolaprilat in isolated canine coronary arteries.
    Desta B; Nakashima M; Kirchengast M; Vanhoutte PM; Boulanger CM
    J Pharmacol Exp Ther; 1995 Feb; 272(2):885-91. PubMed ID: 7531766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the angiotensin converting enzyme by perindoprilat and release of nitric oxide.
    Desta B; Vanhoutte PM; Boulanger CM
    Am J Hypertens; 1995 May; 8(5 Pt 2):1S-6S. PubMed ID: 7544135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation by trandolaprilat of the endothelium-dependent hyperpolarization induced by bradykinin.
    Illiano S; Mombouli JV; Nagao T; Vanhoutte PM
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S6-10. PubMed ID: 7527103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endothelium and vascular effects of the ACE inhibitor trandolaprilat.
    Vidal M; Joly G; Mombouli JV; Boulanger CM; Vanhoutte PM
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S1-5. PubMed ID: 7527094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
    Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
    Hecker M; Bara AT; Busse R
    Eur Heart J; 1993 Nov; 14 Suppl I():161-3. PubMed ID: 8293768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors.
    Mombouli JV; Illiano S; Nagao T; Scott-Burden T; Vanhoutte PM
    Circ Res; 1992 Jul; 71(1):137-44. PubMed ID: 1318793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide and effects of cationic polypeptides in canine cerebral arteries.
    Kinoshita H; Katusic ZS
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):470-80. PubMed ID: 9143230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of bradykinin B1 and B2 receptors in relaxation of mouse isolated trachea.
    Li L; Vaali K; Paakkari I; Vapaatalo H
    Br J Pharmacol; 1998 Apr; 123(7):1337-42. PubMed ID: 9579728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium-dependent relaxation to bradykinin in human small resistance-like coronary arteries.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1997 Mar; 120(5):757-62. PubMed ID: 9138678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinin suppresses endothelin-induced contraction of coronary, renal and femoral arteries through its B2-receptor on the endothelium.
    Ohde H; Morimoto S; Ohnishi K; Yamaoka E; Fukuo K; Yasuda O; Ogihara T
    Agents Actions Suppl; 1992; 38 ( Pt 3)():14-22. PubMed ID: 1334347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms underlying endothelium-dependent, nitric oxide- and prostanoid-independent relaxation in monkey and dog coronary arteries.
    Fujioka H; Ayajiki K; Shinozaki K; Toda N; Okamura T
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):488-95. PubMed ID: 12382080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
    Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G
    Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kininase-independent potentiation of endothelium-dependent relaxations to kinins by converting enzyme inhibitor perindoprilat.
    Mombouli JV; Ballard KD; Vanhoutte PM
    Acta Pharmacol Sin; 2002 Mar; 23(3):203-7. PubMed ID: 11918842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of endothelium-derived relaxing factors released by bradykinin in human resistance arteries.
    Ohlmann P; Martínez MC; Schneider F; Stoclet JC; Andriantsitohaina R
    Br J Pharmacol; 1997 Jun; 121(4):657-64. PubMed ID: 9208131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-dependent relaxations mediated by inducible B1 and constitutive B2 kinin receptors in the bovine isolated coronary artery.
    Drummond GR; Cocks TM
    Br J Pharmacol; 1995 Nov; 116(5):2473-81. PubMed ID: 8581287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of converting enzyme inhibition on endothelial bradykinin metabolism and endothelium-dependent vascular relaxation.
    Bossaller C; Auch-Schwelk W; Gräfe M; Graf K; Baumgarten C; Fleck E
    Agents Actions Suppl; 1992; 38 ( Pt 3)():171-7. PubMed ID: 1334349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of endothelium-dependent relaxations four weeks after ischemia and progressive reperfusion in canine coronary arteries.
    Lee JJ; Olmos L; Vanhoutte PM
    Proc Assoc Am Physicians; 1996 Sep; 108(5):362-7. PubMed ID: 8902880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: enhancement by exercise-training.
    Mombouli JV; Nakashima M; Hamra M; Vanhoutte PM
    Br J Pharmacol; 1996 Feb; 117(3):413-418. PubMed ID: 8821528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement mediates attenuation of endothelium-dependent relaxations in canine coronary arteries after porcine serum exposure: a mechanism for vascular thrombosis in xenograft hyperacute rejection.
    Cable DG; Hisamochi K; Schaff HV
    Circulation; 1997 Nov; 96(9 Suppl):II-58-63; discussion II-63-4. PubMed ID: 9386076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.